AbstractIn response to the limitations of the traditional quality control (QC) model for clinical trials of new traditional Chinese medicine (TCM) drugs, this paper explores the construction of a full-process intelligent QC system centered on artificial intelligence (AI) technology. From the perspective of clinical trial institutions, by integrating currently relatively mature AI technologies, this paper proactively plans QC application scenarios for clinical trials of new TCM drugs and proposes an intelligent QC system architecture covering the entire process before, during, and after the trial. It focuses on elaborating the framework, module composition, main functions, key technical features, and implementation pathways of the intelligent QC system, including data security, management of drugs and biospecimens, protocol evaluation and start-up preparation, intelligent screening and recruitment, risk monitoring and early warning, data governance and quality assessment, and knowledge accumulation and mining. The clinical trial QC system deeply integrated with AI technology can enable institutions to achieve a paradigm shift in QC, shifting from passive response to active prevention and from post-hoc verification to real-time monitoring, thereby improving the quality and efficiency of clinical trials.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |